National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Green, Carmen R, Cowan, Penney, Elk, Ronit et al. · Annals of internal medicine · 2015 · DOI
Quick Summary
In 2015, the National Institutes of Health organized a major workshop bringing together experts to review what scientists know about ME/CFS and identify the most important questions that still need answers. The experts reviewed existing research evidence, listened to presentations, and considered feedback from patients and the public to create a roadmap for future research studies. This effort helped the U.S. medical and research community agree on which ME/CFS research areas should receive priority and funding.
Why It Matters
This NIH workshop established a consensus-based research agenda that has guided ME/CFS funding and study design for nearly a decade, directly influencing which questions scientists prioritize and how research resources are allocated. By identifying specific gaps in evidence, the workshop helped legitimize ME/CFS as a research priority at the federal level and provided a framework for addressing fundamental unknowns about disease mechanisms, diagnosis, and treatment.
Observed Findings
• Major research gaps were identified across ME/CFS disease mechanisms, pathophysiology, and etiology
• Lack of consensus diagnostic criteria was recognized as a critical barrier to research progress
• Insufficient evidence existed regarding effective treatments and rehabilitation strategies
• The need for longitudinal studies and natural history research was emphasized
• Interdisciplinary collaboration was identified as essential for advancing the field
Inferred Conclusions
• ME/CFS requires coordinated, priority-driven research investment across multiple scientific disciplines
• Establishing standardized research definitions and diagnostic criteria is foundational to future progress
• Significant evidence gaps exist regarding disease mechanisms and treatment efficacy that warrant targeted federal research initiatives
Remaining Questions
• What are the biological mechanisms underlying ME/CFS pathophysiology?
• How can standardized diagnostic criteria be developed and validated for clinical and research use?
• Which interventions are effective and safe for ME/CFS patients across the disease spectrum?
What This Study Does Not Prove
This workshop does not present new experimental data or clinical trial results proving specific treatments work or establishing disease mechanisms. It is a consensus document identifying research needs rather than demonstrating causation or establishing clinical efficacy. The priorities identified reflect the 2015 state of knowledge and may not capture discoveries made after the workshop.